Lv4
700 积分 2025-05-07 加入
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis
1天前
已完结
Therapeutic challenges in peripheral T-cell lymphoma
1个月前
已完结
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
1个月前
已完结
Management of T-cell malignancies: Bench-to-bedside targeting of epigenetic biology
1个月前
已完结
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
1个月前
已完结
Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study
1个月前
已完结
Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targets
2个月前
已完结
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
2个月前
已完结
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry
2个月前
已完结
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
2个月前
已完结
皖公网安备34019202002308
